Form 4 for TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Accepted 2026-06-08 16:01:07 ET · period of report 2026-06-05 · accession 0001193125-26-261660 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-06-08 16:01 | 2026-06-05 | TEVA | Francis Richard D | Pres, CEO | M - OptEx | — | +13.0K | 1.18M | +1% | — |
| DT | 2026-06-08 16:01 | 2026-06-05 | TEVA | Francis Richard D | Pres, CEO | S - Sale+OE | $34.35 | -6,153 | 1.18M | -0.5% | -$211.4K |
| DT | 2026-06-08 16:01 | 2026-06-05 | TEVA | Francis Richard D | Pres, CEO | M - OptEx | $0.00 | -13.0K | 39.1K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-06-05 | M | A | 13,043 | — | 1,183,682 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. |
| 2 | Common | Ordinary Shares | 2026-06-05 | S | D | 6,153 | $34.35 | 1,177,529 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F3) The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2025. (F4) Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II. |
| 3 | Derivative | Restricted Share Units | 2026-06-05 | M | D | 13,043 | $0.00 | 39,130 | D | — · — to — | 13,043 Ordinary Shares | (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F5) Restricted share units were granted on June 5, 2025, with 13,043 vested on June 5, 2026, 13,043 vesting on each of June 5, 2027 and June 5, 2028, and 13,044 vesting on June 5, 2029. (F5) Restricted share units were granted on June 5, 2025, with 13,043 vested on June 5, 2026, 13,043 vesting on each of June 5, 2027 and June 5, 2028, and 13,044 vesting on June 5, 2029. (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. |